Kite Pharma, Inc. News - KITE

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on October 3, 2017 Registration No. 333-196978 Regist...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on October 3, 2017 Registration No. 333-196978 Regist...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on October 3, 2017 Registration No. 333-196978 Regist...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on October 3, 2017 Registration No. 333-196978 Regist...

Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)

As filed with the Securities and Exchange Commission on October 3, 2017 Registration No. 333-208382 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...

(25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Amended Statement of Ownership: Solicitation (sc 14d9/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a...

Amended Tender Offer Statement by Third Party (sc To-t/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of the tender offer by its wholly-owned subsidiary, Dodgers...

Amended Statement of Ownership: Solicitation (sc 14d9/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Kite Pharma, Inc. (KITE)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

KITE News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

Amended Statement of Ownership (sc 13g/a)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)

Current Report Filing (8-k)

(25-NSE)

Amended Statement of Ownership: Solicitation (sc 14d9/a)

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

Amended Tender Offer Statement by Third Party (sc To-t/a)

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Amended Statement of Ownership: Solicitation (sc 14d9/a)

KITE Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Kite Pharma, Inc. (KITE) News

Kite Pharma, Inc. (KITE)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

KITE News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

Amended Statement of Ownership (sc 13g/a)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)

Current Report Filing (8-k)

(25-NSE)

Amended Statement of Ownership: Solicitation (sc 14d9/a)

Gilead Sciences Completes Acquisition of Kite Pharma, Inc.

Amended Tender Offer Statement by Third Party (sc To-t/a)

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Amended Statement of Ownership: Solicitation (sc 14d9/a)

KITE Discussion

Your Recent History